EU OKs X-Excite sublingual trial against Viagra; SurModics searches for 'secret sauce';

> The European Union's regulatory body has approved a trial by Global Health Ventures for the sulingual version of its X-Excite drug for erectile dysfunction. The trial will compare X-Excite with Pfizer's Viagra. Global Health Ventures release

> Drug-delivery company SurModics, fresh from a standoff with activist shareholder Ramius and a management shakeup, is still searching for its "secret sauce." The Minnesota company is not saying what that might be, but there is speculation that it will not involve pharmaceuticals. Story

> The American Association of Pharmaceutical Scientists is sponsoring an annual award to acknowledge excellence in graduate-level research on lipid excipients in development of oral and topical drug delivery systems. Deadline is May 11. Announcement

Drug delivery patent application of the week: Drug delivery system for administration of poorly water soluble pharmaceutically active substances Patent application

And Finally... When is a straw a drug-delivery system? When it's for kids, of course. Report

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.